The financing has been provided by Mesa Verde Venture Partners and other investors in Tucson, San Diego, Phoenix and Washington DC.
Mark McWilliams, CEO of Medipacs, said: “We are very pleased with the tremendous response by interested investors in our novel disposable infusion technology and the unique business model we have developed for its commercialization.”